CDC Alert for Hospital Infections due to Candida Auris Multiresistant

Dra Mirta D’Ambra*

Received:April 29, 2019;   Published: May 03, 2019

DOI: 10.32474/CTGH.2018.02.000136

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

The Centers for Disease Control and Prevention (CDC) has received reports from international health centers that Candida auris multi-drug resistant yeast is causing health-associated invasive infections with high mortality. Some strains of C. auris have high minimum inhibitory concentrations (MIC) to the three main classes of antifungals, severely limiting treatment options. C. auris requires specialized methods for its identification and could be mistakenly identified as another yeast when the procedure is based on traditional biochemical methods. The CDC is aware that a strain of C. auris was detected in the United States in 2013 as part of ongoing surveillance. The experience outside the United States suggests that C. auris has a high potential to cause outbreaks in health centers. Given the presence of C. auris in nine countries on four continents since 2009, the CDC is alerting health centers in the United States to be on the lookout for C. auris infections in patients.

Abstract| Background| Interim Recommendations| Conclusion| References|